MBRX - Moleculin Biotech, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development4,5451,496260.418
Selling General and Administrative4,0902,381477.81
Non Recurring---
Others1866
Total Operating Expenses---
Operating Income or Loss-8,653-3,883-738.228
Income from Continuing Operations
Total Other Income/Expenses Net-1,152-1,152-1,152
Earnings Before Interest and Taxes-9,805-3,926-738.228
Interest Expense--10.132
Income Before Tax-9,805-3,926-748.36
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-9,805-3,926-748.36
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-9,805-3,926-748.36
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-9,805-3,926-748.36